Cover Image
Market Research Report
Product code 
1029953

North America Needle Biopsy Market - Industry Trends and Forecast to 2028

Published: | Data Bridge Market Research Private Limited | 100 Pages | Delivery time: Inquiry

Price

Back to Top
North America Needle Biopsy Market - Industry Trends and Forecast to 2028
Published: August 1, 2021
Data Bridge Market Research Private Limited
Content info: 100 Pages
Delivery time: Inquiry
  • Description
  • Table of Contents
  • List of Tables

North America needle biopsy market is projected to register a CAGR of 7.1% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

North America Needle Biopsy Market, By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable And Reusable), Application (Tumor, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centers, Biopsy Labs, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the North America needle biopsy market are:

  • Rising prevalence of diagnosis of breast cancer and lung cancer
  • Increased demand for minimally invasive surgeries
  • Government initiatives to spread awareness about lung and breast cancer

Market Players:

The key market players for North America needle biopsy market are listed below:

  • Boston Scientific Corporation
  • Hologic, Inc
  • AprioMed AB
  • Amecath
  • Zamar Care
  • Cardinal Health.
  • INRAD, Inc
  • BD
  • Moller Medical GmbH
  • ARGON MEDICAL
  • Merit Medical Systems
  • PAJUNK
  • B. Braun Melsungen AG

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF THE NORTH AMERICA NEEDLE BIOPSY MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 NORTH AMERICA NEEDLE BIOPSY MARKET: SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 END USER LIFELINE CURVE
  • 2.8 DBMR MARKET POSITION GRID
  • 2.9 VENDOR SHARE ANALYSIS
  • 2.10 MARKET PROCEDURE COVERAGE GRID
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

5 NORTH AMERICA NEEDLE BIOPSY MARKET: REGULATIONS

5.1 REGULATION IN US:

5.2 REGULATION IN EUROPE:

  • 5.3 REGULATIONS IN CHINA

5.4 MEDICAL DEVICE INSTRUCTIONS FOR LABELLING IN CHINA:

  • 5.5 REGULATIONS IN JAPAN
  • 5.6 REGUALTION IN INDIA

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 INCREASED PREVALENCE OF BREAST AND LUNG CANCER
    • 6.1.2 SURGE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES
    • 6.1.3 GOVERNMENT INITIATIVES TO SPREAD AWARENESS ABOUT LUNG AND BREAST CANCER
    • 6.1.4 TECHNOLOGICAL ADVANCEMENT IN NEEDLE BIOPSY
    • 6.1.5 HEALTHCARE REIMBURSEMENT FOR NEEDLE BIOPSY
  • 6.2 RESTRAINTS
    • 6.2.1 RISE IN COST OF THE NEEDLE BIOPSY
    • 6.2.2 RAPID DEVELOPMENT OF ULTRASENSITIVE IMAGING TECHNOLOGIES SUCH AS MAGNETIC RESONANCE IMAGING
    • 6.2.3 RISK OF INFECTION RELATED TO BIOPSY PROCEDURES
    • 6.2.4 COMPLEXITY IN NEEDLE BIOPSY
  • 6.3 OPPORTUNITIES
    • 6.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
    • 6.3.2 RISE IN HEALTHCARE EXPENDITURE AND DISPOSABLE INCOME
    • 1.3.1 INCREASE IN RESEARCH AND DEVELOPMENT ACTIVITIES
    • 6.3.3 HUGE MARKET POTENTIAL IN DEVELOPING COUNTRIES
  • 6.4 CHALLENGES
    • 6.4.1 STRINGENT RULES AND REGULATIONS
    • 6.4.2 RISE IN COMPETITION BETWEEN MARKET PLAYERS
    • 1.4.1 LIMITATIONS OR COMPLICATIONS OF NEEDLE BIOPSY

7 IMPACT OF COVID-19 PANDEMIC ON THE NORTH AMERICA NEEDLE BIOPSY MARKET

  • 7.1 PRICE IMPACT

8 NORTH AMERICA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE

  • 8.1 OVERVIEW
  • 8.2 TREPHINE BIOPSY NEEDLES
    • 8.2.1 REUSABLE
    • 8.2.2 DISPOSABLE
  • 8.3 SALAH NEEDLE ASPIRATION NEEDLE
  • 8.4 KLIMA STERNAL NEEDLE
  • 8.5 JAMSHIDI NEEDLE
  • 8.6 OTHERS

9 NORTH AMERICA NEEDLE BIOPSY MARKET, BY ERGONOMICS

  • 9.1 OVERVIEW
  • 9.2 SHARP
  • 9.3 BLUNT
  • 9.4 CHIBA
  • 9.5 FRANSEEN
  • 9.6 QUINCKE
  • 9.7 OTHERS

10 NORTH AMERICA NEEDLE BIOPSY MARKET, BY PROCEDURE

  • 10.1 OVERVIEW
  • 10.2 FINE-NEEDLE ASPIRATION BIOPSY
  • 10.3 CORE NEEDLE BIOPSY
  • 10.4 IMAGE-GUIDED BIOPSY
  • 10.5 VACUUM ASSISTED BIOPSY

11 NORTH AMERICA NEEDLE BIOPSY MARKET, BY SAMPLE SITE

  • 11.1 OVERVIEW
  • 11.2 BONES
  • 11.3 MUSCLES
  • 11.4 OTHER ORGANS
    • 11.4.1 BREAST
    • 11.4.2 LIVER
    • 11.4.3 LUNGS
    • 11.4.4 OTHERS

12 NORTH AMERICA NEEDLE BIOPSY MARKET, BY UTILITY

  • 12.1 OVERVIEW
  • 12.2 DISPOSABLE
  • 12.3 REUSABLE

13 NORTH AMERICA NEEDLE BIOPSY MARKET, BY APPLICATION

  • 13.1 OVERVIEW
  • 13.2 TUMOR
    • 13.2.1 CARCINOMA
    • 13.2.2 SARCOMA
    • 13.2.3 BLASTOMA
    • 13.2.4 GERM CELL TUMOR
    • 13.2.5 OTHERS
  • 13.3 INFECTION
  • 13.4 INFLAMMATION
  • 13.5 OTHERS

14 NORTH AMERICA NEEDLE BIOPSY MARKET, BY END USER

  • 14.1 OVERVIEW
  • 14.2 HOSPITALS
  • 14.3 DIAGNOSTIC CENTERS
  • 14.4 BIOPSY LABS
  • 14.5 AMBULATORY SURGICAL CENTERS
  • 14.6 ACADEMIC AND RESEARCH ORGANIZATION
  • 14.7 OTHERS

15 NORTH AMERICA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL

  • 15.1 OVERVIEW
  • 15.2 DIRECT TENDER
  • 15.3 RETAIL SALES

16 NORTH AMERICA NEEDLE BIOPSY MARKET, BY REGION

  • 16.1 NORTH AMERICA
    • 16.1.1 U.S.
    • 16.1.2 CANADA
    • 16.1.3 MEXICO

17 NORTH AMERICA NEEDLE BIOPSY MARKET: COMPANY LANDSCAPE

  • 17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

18 SWOT ANALYSIS

19 COMPANY PROFILE

  • 19.1 BOSTON SCIENTIFIC CORPORATION
    • 19.1.1 COMPANY SNAPSHOT
    • 19.1.2 REVENUE ANALYSIS
    • 19.1.3 COMPANY SHARE ANALYSIS
    • 19.1.4 PRODUCT PORTFOLIO
    • 19.1.5 RECENT DEVELOPMENTS
  • 19.2 HOLOGIC, INC
    • 19.2.1 COMPANY SNAPSHOT
    • 19.2.2 REVENUE ANALYSIS
    • 19.2.3 COMPANY SHARE ANALYSIS
    • 19.2.4 PRODUCT PORTFOLIO
    • 19.2.5 RECENT DEVELOPMENTS
  • 19.3 BD
    • 19.3.1 COMPANY SNAPSHOT
    • 19.3.2 REVENUE ANALYSIS
    • 19.3.3 COMPANY SHARE ANALYSIS
    • 19.3.4 PRODUCT PORTFOLIO
    • 19.3.5 RECENT DEVELOPMENTS
  • 19.4 B. BRAUN MELSUNGEN AG
    • 19.4.1 COMPANY SNAPSHOT
    • 19.4.2 REVENUE ANALYSIS
    • 19.4.3 COMPANY SHARE ANALYSIS
    • 19.4.4 PRODUCT PORTFOLIO
    • 19.4.5 RECENT DEVELOPMENTS
  • 19.5 COOK
    • 19.5.1 COMPANY SNAPSHOT
    • 19.5.2 COMPANY SHARE ANALYSIS
    • 19.5.3 PRODUCT PORTFOLIO
    • 19.5.4 RECENT DEVELOPMENTS
  • 19.6 AMECATH
    • 19.6.1 COMPANY SNAPSHOT
    • 19.6.2 PRODUCT PORTFOLIO
    • 19.6.3 RECENT DEVELOPMENTS
  • 19.7 APRIOMED, AB
    • 19.7.1 COMPANY SNAPSHOT
    • 19.7.2 PRODUCT PORTFOLIO
    • 19.7.3 RECENT DEVELOPMENT
  • 19.8 ARGON MEDICAL
    • 19.8.1 COMPANY SNAPSHOT
    • 19.8.2 PRODUCT PORTFOLIO
    • 19.8.3 RECENT DEVELOPMENT
  • 19.9 CARDINAL HEALTH
    • 19.9.1 COMPANY SNAPSHOT
    • 19.9.2 REVENUE ANALYSIS
    • 19.9.3 PRODUCT PORTFOLIO
    • 19.9.4 RECENT DEVELOPMENT
  • 19.10 HAKKO CO., LTD.
    • 19.10.1 COMPANY SNAPSHOT
    • 19.10.2 PRODUCT PORTFOLIO
    • 19.10.3 RECENT DEVELOPMENT
  • 19.11 INRAD, INC.
    • 19.11.1 COMPANY SNAPSHOT
    • 19.11.2 PRODUCT PORTFOLIO
    • 19.11.3 RECENT DEVELOPMENT
  • 19.12 MEDAX SRL
    • 19.12.1 COMPANY SNAPSHOT
    • 19.12.2 PRODUCT PORTFOLIO
    • 19.12.3 RECENT DEVELOPMENT
  • 19.13 MERIT MEDICAL SYSTEMS
    • 19.13.1 COMPANY SNAPSHOT
    • 19.13.2 REVENUE ANALYSIS
    • 19.13.3 PRODUCT PORTFOLIO
    • 19.13.4 RECENT DEVELOPMENTS
  • 19.14 MOLLER MEDICAL GMBH
    • 19.14.1 COMPANY SNAPSHOT
    • 19.14.2 PRODUCT PORTFOLIO
    • 19.14.3 RECENT DEVELOPMENTS
  • 19.15 PAJUNK
    • 19.15.1 COMPANY SNAPSHOT
    • 19.15.2 PRODUCT PORTFOLIO
    • 19.15.3 RECENT DEVELOPMENT
  • 19.16 ST. STONE MEDICAL DEVICES PVT. LTD.
    • 19.16.1 COMPANY SNAPSHOT
    • 19.16.2 PRODUCT PORTFOLIO
    • 19.16.3 RECENT DEVELOPMENT
  • 19.17 SWASTIK ENTERPRISE
    • 19.17.1 COMPANY SNAPSHOT
    • 19.17.2 PRODUCT PORTFOLIO
    • 19.17.3 RECENT DEVELOPMENT
  • 19.18 TSUNAMI MEDICAL SRL
    • 19.18.1 COMPANY SNAPSHOT
    • 19.18.2 PRODUCT PORTFOLIO
    • 19.18.3 RECENT DEVELOPMENTS
  • 19.19 WELL GO MEDICAL PRODUCTS GMBH
    • 19.19.1 COMPANY SNAPSHOT
    • 19.19.2 PRODUCT PORTFOLIO
    • 19.19.3 RECENT DEVELOPMENT
  • 19.20 ZAMAR CARE
    • 19.20.1 COMPANY SNAPSHOT
    • 19.20.2 PRODUCT PORTFOLIO
    • 19.20.3 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NORTH AMERICA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 2 NORTH AMERICA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 3 NORTH AMERICA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 4 NORTH AMERICA SALAH NEEDLE ASPIRATION NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 5 NORTH AMERICA KLIMA STERNAL NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 6 NORTH AMERICA JAMSHIDI NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 7 NORTH AMERICA OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 8 NORTH AMERICA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 9 NORTH AMERICA SHARP IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 10 NORTH AMERICA BLUNT IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 11 NORTH AMERICA CHIBA IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 12 NORTH AMERICA FRANSEEN IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 13 NORTH AMERICA QUINCKE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 14 NORTH AMERICA OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 15 NORTH AMERICA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 16 NORTH AMERICA FINE NEEDLE ASPIRATION BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 17 NORTH AMERICA CORE NEEDLE BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 18 NORTH AMERICA IMAGE GUIDED BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 19 NORTH AMERICA VACUUM ASSITED BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 20 NORTH AMERICA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 21 NORTH AMERICA BONES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 22 NORTH AMERICA MUSCLES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 23 NORTH AMERICA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION
  • TABLE 24 NORTH AMERICA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 25 NORTH AMERICA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA DISPOSABLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 27 NORTH AMERICA REUSABLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 28 NORTH AMERICA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 29 NORTH AMERICA TUMOR IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 30 NORTH AMERICA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 31 NORTH AMERICA INFECTION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA INFLAMMATION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 33 NORTH AMERICA OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 34 NORTH AMERICA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA HOSPITALS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA DIAGNOSTIC CENTERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 37 NORTH AMERICA BIOPSY LABS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA ACADEMIC AND RESEARCH ORGANIZATION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 40 NORTH AMERICA OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 41 NORTH AMERICA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 42 NORTH AMERICA DIRECT TENDER IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 43 NORTH AMERICA RETAIL SALES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 44 NORTH AMERICA NEEDLE BIOPSY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 45 NORTH AMERICA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 46 NORTH AMERICA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 47 NORTH AMERICA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 48 NORTH AMERICA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 49 NORTH AMERICA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 50 NORTH AMERICA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 NORTH AMERICA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 55 NORTH AMERICA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 56 U.S. NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 57 U.S. TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 58 U.S. NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 59 U.S. NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 60 U.S. NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 61 U.S. OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 62 U.S. NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 63 U.S. NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 64 U.S. TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 65 U.S. NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 66 U.S. NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 67 CANADA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 68 CANADA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 69 CANADA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 70 CANADA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 71 CANADA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 72 CANADA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 73 CANADA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 74 CANADA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 75 CANADA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 76 CANADA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 77 CANADA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 78 MEXICO NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 79 MEXICO TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 80 MEXICO NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 81 MEXICO NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 82 MEXICO NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 83 MEXICO OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 84 MEXICO NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 85 MEXICO NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 86 MEXICO TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 87 MEXICO NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 88 MEXICO NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA NEEDLE BIOPSY MARKET: SEGMENTATION
  • FIGURE 2 NORTH AMERICA NEEDLE BIOPSY MARKET: DATA TRIANGULATION
  • FIGURE 3 NORTH AMERICA NEEDLE BIOPSY MARKET: DROC ANALYSIS
  • FIGURE 4 NORTH AMERICA NEEDLE BIOPSY MARKET: NORTH AMERICA VS REGIONAL ANALYSIS
  • FIGURE 5 NORTH AMERICA NEEDLE BIOPSY MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 NORTH AMERICA NEEDLE BIOPSY MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 NORTH AMERICA NEEDLE BIOPSY MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 NORTH AMERICA NEEDLE BIOPSY MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 9 NORTH AMERICA NEEDLE BIOPSY MARKET: MARKET PROCEDURE OVERAGE GRID
  • FIGURE 10 NORTH AMERICA NEEDLE BIOPSY MARKET: SEGMENTATION
  • FIGURE 11 RISING PREVALENCE OF BREAST AND LUNG CANCER, AND INCREASE IN DEMAND OF MINIMALLY INVASIVE SURGERIES AND PRESENCE OF HEALTHCARE REIMBURSEMENT IS EXPECTED TO DRIVE THE NORTH AMERICA NEEDLE BIOPSY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 12 REAGENTS & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NEEDLE BIOPSY MARKET IN 2021 & 2028
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPRTUNITIES AND CHALLENGES OF NORTH AMERICA NEEDLE BIOPSY MARKET
  • FIGURE 14 PREVALENCE OF BREAST CANCER IN EUROPE, INDIA AND IN THE U.S.
  • FIGURE 15 PREVALENCE OF LUNG CANCER IN VARIOUS COUNTRIES, WITH HUNGARY BEING THE HIGHEST PREVALENCE RATE IN WOMEN AND MEN
  • FIGURE 16 NORTH AMERICA NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, 2020
  • FIGURE 17 NORTH AMERICA NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, 2021-2028 (USD MILLION)
  • FIGURE 18 NORTH AMERICA NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, CAGR (2021-2028)
  • FIGURE 19 NORTH AMERICA NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, LIFELINE CURVE
  • FIGURE 20 NORTH AMERICA NEEDLE BIOPSY MARKET: BY ERGONOMICS, 2020
  • FIGURE 21 NORTH AMERICA NEEDLE BIOPSY MARKET: BY ERGONOMICS, 2021-2028 (USD MILLION)
  • FIGURE 22 NORTH AMERICA NEEDLE BIOPSY MARKET: BY ERGONOMICS, CAGR (2021-2028)
  • FIGURE 23 NORTH AMERICA NEEDLE BIOPSY MARKET: BY ERGONOMICS, LIFELINE CURVE
  • FIGURE 24 NORTH AMERICA NEEDLE BIOPSY MARKET: BY PROCEDURE, 2020
  • FIGURE 25 NORTH AMERICA NEEDLE BIOPSY MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)
  • FIGURE 26 NORTH AMERICA NEEDLE BIOPSY MARKET: BY PROCEDURE, CAGR (2021-2028)
  • FIGURE 27 NORTH AMERICA NEEDLE BIOPSY MARKET: BY PROCEDURE, LIFELINE CURVE
  • FIGURE 28 NORTH AMERICA NEEDLE BIOPSY MARKET: BY SAMPLE SITE, 2020
  • FIGURE 29 NORTH AMERICA NEEDLE BIOPSY MARKET: BY SAMPLE SITE, 2021-2028 (USD MILLION)
  • FIGURE 30 NORTH AMERICA NEEDLE BIOPSY MARKET: BY SAMPLE SITE, CAGR (2021-2028)
  • FIGURE 31 NORTH AMERICA NEEDLE BIOPSY MARKET: BY SAMPLE SITE, LIFELINE CURVE
  • FIGURE 32 NORTH AMERICA NEEDLE BIOPSY MARKET: BY UTILITY, 2020
  • FIGURE 33 NORTH AMERICA NEEDLE BIOPSY MARKET: BY UTILITY, 2021-2028 (USD MILLION)
  • FIGURE 34 NORTH AMERICA NEEDLE BIOPSY MARKET: BY UTILITY, CAGR (2021-2028)
  • FIGURE 35 NORTH AMERICA NEEDLE BIOPSY MARKET: BY UTILITY, LIFELINE CURVE
  • FIGURE 36 NORTH AMERICA NEEDLE BIOPSY MARKET: BY APPLICATION, 2020
  • FIGURE 37 NORTH AMERICA NEEDLE BIOPSY MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
  • FIGURE 38 NORTH AMERICA NEEDLE BIOPSY MARKET: BY APPLICATION, CAGR (2021-2028)
  • FIGURE 39 NORTH AMERICA NEEDLE BIOPSY MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 40 NORTH AMERICA NEEDLE BIOPSY MARKET: BY END USER, 2020
  • FIGURE 41 NORTH AMERICA NEEDLE BIOPSY MARKET: BY END USER, 2021-2028 (USD MILLION)
  • FIGURE 42 NORTH AMERICA NEEDLE BIOPSY MARKET: BY END USER, CAGR (2021-2028)
  • FIGURE 43 NORTH AMERICA NEEDLE BIOPSY MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 44 NORTH AMERICA NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 45 NORTH AMERICA NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • FIGURE 46 NORTH AMERICA NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
  • FIGURE 47 NORTH AMERICA NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 48 NORTH AMERICA NEEDLE BIOPSY MARKET: SNAPSHOT (2020)
  • FIGURE 49 NORTH AMERICA NEEDLE BIOPSY MARKET: BY REGION (2020)
  • FIGURE 50 NORTH AMERICA NEEDLE BIOPSY MARKET: BY REGION (2021 & 2028)
  • FIGURE 51 NORTH AMERICA NEEDLE BIOPSY MARKET: BY REGION (2020 & 2028)
  • FIGURE 52 NORTH AMERICA NEEDLE BIOPSY MARKET: BY NEEDLE TYPE (2021-2028)
  • FIGURE 53 NORTH AMERICA NEEDLE BIOPSY MARKET: COMPANY SHARE 2020 (%)